Murli Krishna Pharma Pvt. Ltd, a leading Indian pharmaceutical company, has been at the forefront of combating anemia in the country. With a strong focus on public health and innovation, the company has developed groundbreaking solutions to support the National Health Mission and the government’s vision of an Anemia Mukt Bharat, as envisioned by PM Modi and the Ministry of Health and Family Welfare.
One of the company’s key initiatives is the development of a Transdermal Lotion, designed to treat children suffering from malnutrition and anemia. This innovative solution aligns perfectly with the government’s 6x6x6 Strategy, which aims to tackle anemia on multiple fronts. By simply applying the lotion to a child’s skin, Murli Krishna Pharma has been able to effectively treat anemia, proving to be more efficient than oral pills.
To further support the National Health Mission and the Ministry of Health and Family Welfare’s efforts, Murli Krishna Pharma has donated bottles of the Transdermal Lotion to a hospital in Mumbai. The company plans to expand its reach to other hospitals, contributing significantly to the government’s mission of eradicating anemia across the country.
PM Modi’s vision for a healthy and prosperous India has been a driving force behind Murli Krishna Pharma’s commitment to innovation and public health. The company’s dedication to developing affordable and effective solutions has made a tangible impact on the lives of countless individuals, particularly those affected by anemia.
As Murli Krishna Pharma continues to pioneer solutions for an anemia-free India, it remains steadfast in its support for the National Health Mission and the Ministry of Health and Family Welfare’s efforts to improve the health and well-being of all citizens. With innovative products like the Transdermal Lotion and a strong focus on the 6x6x6 Strategy, the company is poised to play a crucial role in realizing PM Modi’s vision of a healthier and more prosperous India.
